The Experts below are selected from a list of 237 Experts worldwide ranked by ideXlab platform
Taymour Mostafa - One of the best experts on this subject based on the ideXlab platform.
-
spontaneous penile Tumescence by sparing cavernous tissue in the course of malleable penile prosthesis implantation
The Journal of Sexual Medicine, 2019Co-Authors: Adham Zaazaa, Taymour MostafaAbstract:INTRODUCTION: Spontaneous penile Tumescence after penile prosthesis implantation has been sporadically reported in the literature. AIM: To preserve residual erectile function of patients' spontaneous penile Tumescence by sparing cavernous tissue in the course of malleable penile prosthesis implantation. METHODS: Overall, 92 patients were randomized into 2 equal arms; patients undergoing conventional malleable penile prosthesis implantation, and patients undergoing the cavernous tissue-sparing technique. 1 month after surgery, these patients underwent penile duplex examination to assess the maximal cavernous tissue thickness around the implant cylinders. Additionally, they were asked about the occurrence of any spontaneous or arousal-induced penile Tumescence. MAIN OUTCOME MEASURES: Postoperative changes were compared with the preoperative ones. RESULTS: The mean maximal cavernous tissue thickness was shown to be significantly higher in the cavernous tissue-sparing group compared with the conventional surgery group (5.2 ± 0.8 mm vs 2.2 ± 1.04 mm, P < .01). In the cavernous tissue-sparing group, 41 of 46 patients (89.13%) reported having a significantly higher incidence of residual penile Tumescence vs 7 of 46 patients (15.2%) in the conventional surgery group (P < .001). The postoperative penile girth was significantly higher in the cavernous tissue-sparing group than in the conventional surgery group (11.16 ± 1.1 cm vs 10.11 ± 1.15 cm, P < .001). CLINICAL IMPLICATIONS: This study provides a step-by-step approach to maintaining post-implantation penile Tumescence and preserving penile girth in a reproducible manner. STRENGTHS & LIMITATIONS: This is the first study to demonstrate the benefits of implanting a penile prosthesis while the penis is in a pharmacologically induced tumescent state. It is also the first to make use of ultrasound imaging in assessing postoperative corporal tissue. The main limitations are the short postoperative follow-up period and the non-blinding of measurements. CONCLUSION: It could be concluded that the cavernous tissue-sparing technique is a reproducible technique that has the added value of preserving residual erectile function in the form of retained postoperative penile Tumescence and preserved penile girth. Zaazaa A, Mostafa T. Spontaneous Penile Tumescence by Sparing Cavernous Tissue in the Course of Malleable Penile Prosthesis Implantation. J Sex Med 2019;16:474-478.
-
Spontaneous Penile Tumescence by Sparing Cavernous Tissue in the Course of Malleable Penile Prosthesis Implantation.
The Journal of Sexual Medicine, 2019Co-Authors: Adham Zaazaa, Taymour MostafaAbstract:INTRODUCTION: Spontaneous penile Tumescence after penile prosthesis implantation has been sporadically reported in the literature. AIM: To preserve residual erectile function of patients' spontaneous penile Tumescence by sparing cavernous tissue in the course of malleable penile prosthesis implantation. METHODS: Overall, 92 patients were randomized into 2 equal arms; patients undergoing conventional malleable penile prosthesis implantation, and patients undergoing the cavernous tissue-sparing technique. 1 month after surgery, these patients underwent penile duplex examination to assess the maximal cavernous tissue thickness around the implant cylinders. Additionally, they were asked about the occurrence of any spontaneous or arousal-induced penile Tumescence. MAIN OUTCOME MEASURES: Postoperative changes were compared with the preoperative ones. RESULTS: The mean maximal cavernous tissue thickness was shown to be significantly higher in the cavernous tissue-sparing group compared with the conventional surgery group (5.2 ± 0.8 mm vs 2.2 ± 1.04 mm, P
Sharon P Viosca - One of the best experts on this subject based on the ideXlab platform.
-
use of a vacuum Tumescence device in the management of impotence in men with a history of penile implant or severe pelvic disease
Journal of the American Geriatrics Society, 1992Co-Authors: Stanley G Korenman, Sharon P VioscaAbstract:Purpose To evaluate the use of a vacuum Tumescence device in the treatment of impotence in couples wishing to restore coital function, whose male partners had unsatisfactory results from penile implants or in whom the man was impotent following treatment for prostate or colon carcinoma. Subjects Convenience sample of seventeen couples seeking treatment of male factor sexual dysfunction. Methods After completion of a comprehensive diagnostic evaluation of the male partner, couples who expressed a wish to restore coital function were instructed in the use of the vacuum Tumescence device. Partners each filled out and initialled a daily diary of sexual activity and returned to clinic for followup at 3 and 6 months. Results Sixteen patients were able to obtain firm to hard erections lasting an average of 14.9 minutes and had satisfactory coitus with vaginal ejaculation an average of 3.9 times per month. There were no significant complications. Conclusion The vacuum Tumescence device can be effective in the treatment of impotence after penile prosthesis explantation, in enhancement of inadequate erections with a prosthesis in place, and after surgical or radiation therapy for prostate or colon carcinoma.
-
use of a vacuum Tumescence device in the management of impotence
Journal of the American Geriatrics Society, 1990Co-Authors: Stanley G Korenman, Sharon P Viosca, Fran E Kaiser, Arshag D Mooradian, John E MorleyAbstract:: This study evaluated the use of a vacuum Tumescence device in the treatment of impotence in older men. Twenty couples with sexual dysfunction due to erectile impotence and who were interested in restoration of sexual function were treated by providing them with both a vacuum Tumescence device to engorge the penis and an obstructing band to impede venous return. Nineteen patients established firm to hard erections lasting an average of 16 minutes and were able to have satisfactory coitus with vaginal ejaculation an average of three times per month. The penile-brachial pressure index, supine and after exercise (a measure of the adequacy of penile arterial flow), exhibited a significant increase following six month's use of the vacuum Tumescence device. The only significant complications were mild, self-limited hematomas on three occasions of use. Thus in this limited series the vacuum Tumescence device provided a well-accepted, relatively inexpensive therapeutic approach to impotence.
Stanley G Korenman - One of the best experts on this subject based on the ideXlab platform.
-
use of a vacuum Tumescence device in the management of impotence in men with a history of penile implant or severe pelvic disease
Journal of the American Geriatrics Society, 1992Co-Authors: Stanley G Korenman, Sharon P VioscaAbstract:Purpose To evaluate the use of a vacuum Tumescence device in the treatment of impotence in couples wishing to restore coital function, whose male partners had unsatisfactory results from penile implants or in whom the man was impotent following treatment for prostate or colon carcinoma. Subjects Convenience sample of seventeen couples seeking treatment of male factor sexual dysfunction. Methods After completion of a comprehensive diagnostic evaluation of the male partner, couples who expressed a wish to restore coital function were instructed in the use of the vacuum Tumescence device. Partners each filled out and initialled a daily diary of sexual activity and returned to clinic for followup at 3 and 6 months. Results Sixteen patients were able to obtain firm to hard erections lasting an average of 14.9 minutes and had satisfactory coitus with vaginal ejaculation an average of 3.9 times per month. There were no significant complications. Conclusion The vacuum Tumescence device can be effective in the treatment of impotence after penile prosthesis explantation, in enhancement of inadequate erections with a prosthesis in place, and after surgical or radiation therapy for prostate or colon carcinoma.
-
use of a vacuum Tumescence device in the management of impotence
Journal of the American Geriatrics Society, 1990Co-Authors: Stanley G Korenman, Sharon P Viosca, Fran E Kaiser, Arshag D Mooradian, John E MorleyAbstract:: This study evaluated the use of a vacuum Tumescence device in the treatment of impotence in older men. Twenty couples with sexual dysfunction due to erectile impotence and who were interested in restoration of sexual function were treated by providing them with both a vacuum Tumescence device to engorge the penis and an obstructing band to impede venous return. Nineteen patients established firm to hard erections lasting an average of 16 minutes and were able to have satisfactory coitus with vaginal ejaculation an average of three times per month. The penile-brachial pressure index, supine and after exercise (a measure of the adequacy of penile arterial flow), exhibited a significant increase following six month's use of the vacuum Tumescence device. The only significant complications were mild, self-limited hematomas on three occasions of use. Thus in this limited series the vacuum Tumescence device provided a well-accepted, relatively inexpensive therapeutic approach to impotence.
Ray Over - One of the best experts on this subject based on the ideXlab platform.
-
Psychophysiological assessment of male sexual arousal following spinal cord injury
Archives of Sexual Behavior, 1990Co-Authors: Simon Kennedy, Ray OverAbstract:Adult males with and without permanent damage to the spinal cord were contrasted in terms of their sexual responsiveness to erotic stimulation in film, spoken-text, and fantasy modes. Among the 16 spinal cord injured (SCI) men who were studied, several who had anticipated they would achieve erection failed to do so, whereas others demonstrated penile Tumescence during erotic stimulation despite claiming they had lost the capacity for psychogenic erection. Self-report is thus not a valid index of sexual responsivity following spinal cord injury. Levels of Tumescence varied across modalities of stimulation in the same manner for SCI and non-SCI men, and within each modality the two groups demonstrated similar rates of buildup of arousal over segments of stimulation. The SCI men without erections should not be considered asexual since their subjective arousal paralleled the subjective arousal of the non-SCI men and the SCI men with erections.
John E Morley - One of the best experts on this subject based on the ideXlab platform.
-
use of a vacuum Tumescence device in the management of impotence
Journal of the American Geriatrics Society, 1990Co-Authors: Stanley G Korenman, Sharon P Viosca, Fran E Kaiser, Arshag D Mooradian, John E MorleyAbstract:: This study evaluated the use of a vacuum Tumescence device in the treatment of impotence in older men. Twenty couples with sexual dysfunction due to erectile impotence and who were interested in restoration of sexual function were treated by providing them with both a vacuum Tumescence device to engorge the penis and an obstructing band to impede venous return. Nineteen patients established firm to hard erections lasting an average of 16 minutes and were able to have satisfactory coitus with vaginal ejaculation an average of three times per month. The penile-brachial pressure index, supine and after exercise (a measure of the adequacy of penile arterial flow), exhibited a significant increase following six month's use of the vacuum Tumescence device. The only significant complications were mild, self-limited hematomas on three occasions of use. Thus in this limited series the vacuum Tumescence device provided a well-accepted, relatively inexpensive therapeutic approach to impotence.
